Chengdu Bioteque

Chengdu Bioteque is a Chinese biopharmaceutical company focused on the development and commercialization of innovative oncology therapeutics. The company is best known for its involvement in the production and marketing of Nimotuzumab, a humanized monoclonal antibody targeting the epidermal growth factor receptor (EGFR), which is used in the treatment of various solid tumors. Chengdu Bioteque operates as a key player in the regional biotech ecosystem of Chengdu, leveraging its manufacturing capabilities to supply targeted therapies to the Chinese market. Its portfolio primarily emphasizes targeted biologics and small molecules designed to address unmet needs in cancer care.